Useful Forms – UK NEQAS – ICC & ISH

A) Distribution of ER-positive rates by patient age at test. The final

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

PDF) Best Practice No 176: Updated recommendations for HER2 testing in the UK

e-Journal – UK NEQAS – ICC & ISH

United Kingdom National External Quality Assessment Service for

e-Journal – UK NEQAS – ICC & ISH

Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics

UK NEQAS IQN Path

Assessment Procedure – UK NEQAS – ICC & ISH

PDF) Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM